Want to buy for someone else? You can purchase a token at check out.
Overview
Provides healthcare professionals information about Chagas disease, which is becoming more prevalent in the United States.Goals and Learning Outcomes
Chagas disease is one of the most common causes of congestive heart failure and sudden death in the world. It is caused by Trypanosoma cruzi, a protozoan parasite that is transmitted to humans through the bite wound of an infected triatomine bug, also called the “kissing” bug.
Until recently, Chagas disease was rare in the United States. However, with the increased immigration in the past decades of T. cruzi-infected individuals from disease-endemic countries, Chagas disease is becoming a serious U.S. public health problem. In the United States today, about 300,000 people are infected, with 30,000 to 45,000 undiagnosed cardiomyopathy cases and about 60 to 300 congenital infections each year. Most people with the infection are from Mexico and unaware that they are infected. Healthcare professionals of various disciplines will need a good understanding of the disease, so they can educate infected patients about Chagas and about effective therapeutic options and the availability of treatment.
- Describe the causes, transmission, and symptoms of Chagas disease.
- Discuss why Chagas disease has become a public health problem in the United States.
- Explain why most healthcare professionals are unaware of one of the most common causes of congestive heart failure and sudden death in the world.
- Describe the causes, transmission and symptoms of Chagas disease
- Discuss why Chagas disease has become a public health problem in the U.S.
- Explain why most healthcare professionals are unaware of one of the most common causes of congestive heart failure and sudden death in the world
Course Details
Course Originally Released on : 5/1/2019
REL-ACU-0-CE613
Course Author
MPH, CIC
MS, MPH, RN
Accreditations
NURSES
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Provider approved by the California Board of Registered Nursing, CEP#13791
Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.
CEBroker
Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Examiners For Registered Professional Nurses
Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.
Disclosures
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.